|
|
News Breaks | | | | February 27, 2013 | | 07:32 EDT |  | AH | Accretive Health results likely delayed by incentive fee issue, says Oppenheimer
Oppenheimer believes that the most likely reason for the delay of Accretive Health's results is that auditors have decided that the company should establish a reserve for incentive fees, in light of the company's dispute with Fairview Health over this issue. The firm notes that the company is confident that it will recognize the full amount of revenue from its deal with Fairview, and Oppenheimer maintains an Outperform rating on Accretive. | |
|
News For AH From The Last 14 Days Check below for free stories on AH the last two weeks. |
|
|
| May 14, 2013 | | 17:48 EDT |  | AH | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | |
|
|
|
|
|
|
